Advertising

Rating Card

Unlock Expert's Rating and Top Picks Portfolio

Become a member Or, Sign In
Latest Top Picks

Stock Opinions by David King

TOP PICK
A pure value buy. 9 X trailing PE and 3% yield is intriguing. Headline risk is not as important as were the numbers and up ultimately.
Financial Services
TOP PICK
Betting on the franchise. Benefits from economic recovery on a global basis. Exciting product line with their iGen3. Still cheap.
misc industrial products
BUY
Attractive. Continuing turnaround in their diagnostic business as well as a better pipeline than some of the other chief pharmaceuticals.
biotechnology / pharmaceutical
BUY
A potential takeover play. Has been a bit undermanaged and is very cheap.
biotechnology / pharmaceutical
Showing 1 to 4 of 4 entries
  • «
  • 1
  • »